A and W Revenue Royalties Income Fund (TSE:AW.UN) Raised to Buy at Laurentian

Share on StockTwits

Laurentian upgraded shares of A and W Revenue Royalties Income Fund (TSE:AW.UN) from a hold rating to a buy rating in a research note issued to investors on Thursday, BayStreet.CA reports.

Shares of AW.UN opened at C$38.00 on Thursday. The company has a market capitalization of $534.46 million and a P/E ratio of 20.72. The company has a debt-to-equity ratio of 26.49, a current ratio of 3.29 and a quick ratio of 3.29. A and W Revenue Royalties Income Fund has a one year low of C$30.26 and a one year high of C$47.65. The business’s 50 day simple moving average is C$38.97 and its 200-day simple moving average is C$41.72.

About A and W Revenue Royalties Income Fund

A&W Revenue Royalties Income Fund, a limited purpose trust, holds investment in A&W Trade Marks Inc, which through its ownership interest in A&W Trade Marks Limited Partnership owns the A&W trade-marks used in the A&W quick service restaurant business in Canada. A&W Trade Marks Inc licenses A&W trade-marks to A&W Food Services of Canada Inc As of February 05, 2019, the company had 934 A&W restaurants.

Recommended Story: Cash Asset Ratio

Receive News & Ratings for A and W Revenue Royalties Income Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for A and W Revenue Royalties Income Fund and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Intercorp Financial  to Release Earnings on Tuesday
Intercorp Financial to Release Earnings on Tuesday
Raymond James Research Analysts Decrease Earnings Estimates for WSP Global Inc
Raymond James Research Analysts Decrease Earnings Estimates for WSP Global Inc
FY2019 EPS Estimates for resTORbio, Inc. Decreased by Analyst
FY2019 EPS Estimates for resTORbio, Inc. Decreased by Analyst
Pivotal Research Increases Wolverine World Wide  Price Target to $32.00
Pivotal Research Increases Wolverine World Wide Price Target to $32.00
Kura Sushi USA’s  “Buy” Rating Reaffirmed at Maxim Group
Kura Sushi USA’s “Buy” Rating Reaffirmed at Maxim Group
Collegium Pharmaceutical  Price Target Raised to $22.00 at SunTrust Banks
Collegium Pharmaceutical Price Target Raised to $22.00 at SunTrust Banks


 
© 2006-2019 Zolmax.